Actual Medicinal Product (AMP) - Retsevmo 40mg capsules (Eli Lilly and Company Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Retsevmo 40mg capsules | Start Date 01-04-2021 | End Date |
Summary
- Licensed Route
- Oral
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
- EMA Monitoring
Codes
| Code | Start Date | End Date |
|---|---|---|
| 39420611000001100 | 01-04-2021 |
Parent Products
-
VTMSelpercatinib
-
VMPSelpercatinib 40mg capsules
-
AMP(Current) Retsevmo 40mg capsules (Eli Li...
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 56 capsule | 218400 | |
| 60 capsule | ||
| 168 capsule | 655200 |